Table 1.
Baseline patient characteristics (n = 80).
| General Characteristics | Values |
|---|---|
| Number of patients, n | 80 |
| Age (years) | 56.0 ± 8.14 |
| Gender (f/m) | 24/56 |
| BMI (Kg/m2) | 23.4 |
| Hb (g/dL) | 12.97 ± 1.83 |
| Albumin (g/dL) | 4.27 ± 0.48 |
| ACR (µg/mg) | 137.37 ± 41.11 |
| eGFR (mL/min per 1.73 m2) | 47.26 ± 18.42 |
| Phosphate (P) (mg/dL) | 3.9 ± 0.67 |
| Calcium (Ca) (mg/dL) | 9.48 ± 0.62 |
| Calcium (x) Phosphate (CaxP) | 35.9 ± 5.8 |
| PTH (pg/mL) | 113.11 ± 74.65 |
| FGF-23 (RU/mL) | 135.32 ± 102.20 |
| α-Klotho (pg/mL) | 272.38.10 ± 169.95 |
| IL-6 (pg/mL) | 4.61 ± 2.60 |
| GRP (ng/mL) | 0.90 ± 0.56 |
| HbA1c (%) | 7.67 ± 1.47 |
| Systolic BP (mmHg) | 127.42 ± 8.56 |
| Diastolic BP (mmHg) | 78.58 ± 9.98 |
| PP (mmHg) | 45.65 ± 12.03 |
| VCS (Adragão score) | 2.7 ± 2.3 |
| Diabetes-related CKD evolution time (months) | 73.8 ± 8.7 |
BMI, body mass index; Hb, hemoglobin; ACR, urine albumin to creatinine ratio; eGFR, estimated glomerular filtration rate; PTH, parathyroid hormone; FGF-23, fibroblast growth factor 23; IL-6, interleukin 6; GRP, Gla-rich protein; HbA1c, glycated hemoglobin; BP, blood pressure; PP, pulse pressure; VCS, vascular calcification score.